Literature DB >> 2939715

Use of diclofenac in analgesia.

T G Kantor.   

Abstract

The inhibition of prostaglandin synthesis by nonsteroidal anti-inflammatory drugs can alleviate the pain and inflammation associated with a variety of disorders. Nonsteroidal anti-inflammatory drugs have a role, therefore, in the treatment of nonrheumatic conditions as well as in the treatment of rheumatic diseases, an area in which these agents have been used and studied more extensively. In clinical conditions marked by acute or chronic pain and inflammation, such as oral surgery, dysmenorrhea, low back pain, renal colic, and biliary colic, as well as in post-traumatic and postoperative conditions, diclofenac sodium, a nonsteroidal anti-inflammatory drug with potent prostaglandin synthetase inhibition, has been shown to be an effective analgesic agent. In the current studies, diclofenac was given orally or by intramuscular injection in doses ranging from 50 to 75 mg daily, or up to 150 mg per day for longer-term use. When compared with placebo, diclofenac provided consistently superior relief of symptoms. Comparisons with other nonsteroidal anti-inflammatory drugs or with opioids, such as pentazocine or Spasmofen, demonstrate that symptom relief with diclofenac was either comparable to or better than that obtained with these agents.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2939715     DOI: 10.1016/0002-9343(86)90083-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Summary of the scientific literature for pain and anxiety control in dentistry journal literature, January 1986-December 1987.

Authors:  L C Hassett
Journal:  Anesth Prog       Date:  1988 Nov-Dec

Review 2.  As a painkiller: a review of pre- and postnatal non-steroidal anti-inflammatory drug exposure effects on the nervous systems.

Authors:  Kıymet Kubra Yurt; Suleyman Kaplan
Journal:  Inflammopharmacology       Date:  2017-12-27       Impact factor: 4.473

3.  Diclofenac sodium and spasmolytic drugs in the treatment of ureteral colic: a comparative study.

Authors:  I Başar; K Bircan; C Taşar; A Ergen; F Cakmak; D Remzi
Journal:  Int Urol Nephrol       Date:  1991       Impact factor: 2.370

Review 4.  Diclofenac sodium. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-03       Impact factor: 9.546

5.  [Pain therapy in acute renal colic.].

Authors:  C Tschuschke; S C Müller; L Hertle
Journal:  Schmerz       Date:  1993-09       Impact factor: 1.107

6.  Topical analgesia for superficial corneal injuries.

Authors:  A K Brahma; S Shah; V F Hillier; D McLeod; T Sabala; A Brown; J Marsden
Journal:  J Accid Emerg Med       Date:  1996-05

7.  Effect of drug release rate on therapeutic outcomes: formulation dependence of gastrointestinal toxicity of diclofenac in the rat.

Authors:  Tahereh Khazaeinia; Fakhreddin Jamali
Journal:  Inflammopharmacology       Date:  2004       Impact factor: 4.473

Review 8.  Techniques for post-op pain management in the adult.

Authors:  C Moote
Journal:  Can J Anaesth       Date:  1993-05       Impact factor: 5.063

9.  Single intramuscular injection of diclofenac sodium in febrile pediatric patients.

Authors:  Jun Yeol Lee; Jun Hwi Cho; Myoung Cheol Shin; Taek Geun Ohk; Hui Young Lee; Chan Woo Park
Journal:  Indian J Pharmacol       Date:  2015 May-Jun       Impact factor: 1.200

10.  A rapid magnetic bead-based immunoassay for sensitive determination of diclofenac.

Authors:  Alexander Ecke; Tanja Westphalen; Jane Hornung; Michael Voetz; Rudolf J Schneider
Journal:  Anal Bioanal Chem       Date:  2021-11-20       Impact factor: 4.142

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.